Growth Metrics

Aspen Aerogels (ASPN) Accumulated Expenses (2016 - 2025)

Aspen Aerogels (ASPN) has disclosed Accumulated Expenses for 13 consecutive years, with $5.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Accumulated Expenses fell 66.05% year-over-year to $5.1 million, compared with a TTM value of $5.1 million through Sep 2025, down 66.05%, and an annual FY2024 reading of $19.4 million, up 14.78% over the prior year.
  • Accumulated Expenses was $5.1 million for Q3 2025 at Aspen Aerogels, up from $4.5 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $19.4 million in Q4 2024 and bottomed at $436000.0 in Q2 2021.
  • Average Accumulated Expenses over 5 years is $10.4 million, with a median of $10.8 million recorded in 2021.
  • The sharpest move saw Accumulated Expenses crashed 82.13% in 2021, then surged 2416.74% in 2022.
  • Year by year, Accumulated Expenses stood at $10.8 million in 2021, then soared by 47.92% to $16.0 million in 2022, then rose by 5.46% to $16.9 million in 2023, then grew by 14.78% to $19.4 million in 2024, then plummeted by 73.71% to $5.1 million in 2025.
  • Business Quant data shows Accumulated Expenses for ASPN at $5.1 million in Q3 2025, $4.5 million in Q2 2025, and $3.6 million in Q1 2025.